Showing results (491-500 of 943) with videos related to
Sort By:
Pageof 95
Northern Clinics of Istanbul|August 21, 2025
Assessment of serum vascular endothelial growth factor, nitric oxide and asymmetric dimethyl arginine levels in non-small cell lung cancerEsra Paydas Hataysal, Fikret Kanat, Muslu Kazim Korez, et al.Northern Clinics of Istanbul|August 21, 2025
Investigation of the effects of MTHFR gene variations and homocysteine levels in hypertensive patientsSibel Kuras, Mahmud Esad Pence, Esref Arac, et al.Northern Clinics of Istanbul|August 21, 2025
Rheumatic diseases presenting with young ischemic stroke: Revelations from tertiary center experienceHatice Ecem Konak, Serdar Can Guven, Ebru Atalar, et al.Northern Clinics of Istanbul|August 21, 2025
Comparison of the antibiofilm activity of plant-derived compounds furanone C30 and ellagic acid C11 with antibiotics against Pseudomonas aeruginosaOzge Aksu, Fatma Koksal CakirlarNorthern Clinics of Istanbul|August 21, 2025
Predictive value of machine learning-based T2-weighted MRI radiomics in the diagnosis of polycystic ovary syndromeGunay Rona, Neriman Fistikcioglu, Tekin Ahmet Serel, et al.Northern Clinics of Istanbul|August 22, 2025
Candida auris infection at a pediatric burn center: Treatment and infection control measuresSeval Ozen, Belgin Gulhan, Sabri Demir, et al.Northern Clinics of Istanbul|August 22, 2025
Determination of urinary iodine excretion and iodine deficiency in school-age children aged 7-11 after mandatory iodization in Canakkale, TurkiyeKubra Cevik, Hakan AylancNorthern Clinics of Istanbul|August 22, 2025
Usability assessments in clinical decision support systemsHikmet Can Cubukcu, Hayri CanbazNorthern Clinics of Istanbul|August 22, 2025
Contextual reading and analysis of the team's narratives about the system in which clinical education and healthcare processes are experiencedMerve Saracoglu, Sinem Yildiz Inanici, Mehmet Ali GulpinarNorthern Clinics of Istanbul|January 23, 2026
Infection and infestation-related adverse events of ocrelizumab: A disproportionality analysis using FDA adverse event reporting systemNesrin Caglayan DumanPageof 95